Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron-Reference-Cited by-同舟云学术

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron

Published:2022-05 Issue:5 Volume:40 Page:444-446
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Mair Maximilian J.,Mitterer Manfred,Gattinger Pia,Berger Julia M.,Trutschnig Wolfgang,Bathke Arne C.,Gansterer Margaretha,Berghoff Anna S.,Laengle Severin,Gottmann Lynn,Buratti Thomas,Haslacher Helmuth,Lamm Wolfgang W.,Raderer Markus,Tobudic Selma,Fuereder Thorsten,Valenta Rudolf,Fong Dominic,Preusser Matthias

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference11 articles.

1. Covid-19 vaccine Effectiveness against the Omicron (B.1.1.529) variant;Andrews;N. Engl. J. Med.,2022

2. Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa;Collie;N. Engl. J. Med.,2022

3. Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review;Corti;Ann. Oncol.,2022

4. Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer;Fendler;Lancet,2022

5. Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants;Gattinger;Allergy,2022

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in Lung Transplant Recipients: A Report on 10 Recent Cases;Viruses;2024-04-29

2. Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine;Vaccines;2024-01-19

3. mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer;Journal for ImmunoTherapy of Cancer;2024-01

4. Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with acute leukemia;Annals of Hematology;2023-12-28

5. COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future;The Journal of Infectious Diseases;2023-08-01